Connect with us

Business Wire

Global Cannabidiol Oil Market (2022 to 2027) – Changing Consumer Opinion and Increasing Awareness About the Health Benefits of Cannabinoids is Driving Growth – ResearchAndMarkets.com

Published

on


DUBLIN–(BUSINESS WIRE)–The “Global Cannabidiol Oil Market (2022-2027) by Product, Source, Distribution Channel, Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Cannabidiol Oil Market is estimated to be USD 1.09 Bn in 2022 and is expected to reach USD 3.64 Bn by 2027, growing at a CAGR of 27.28%.

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Cannabidiol Oil Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Cannabidiol Oil Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cannabidiol Oil Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Market Dynamics

Drivers

  • Changing Consumer Opinion and Increasing Awareness about the Health Benefits of Cannabinoids
  • Rise in the Demand for Cannabidiol from various Industries such as Food and Beverage, Personal Care and Cosmetics
  • Increasing use of Cannabidiol Oil and Infused Products in Pharmaceutical Products

Restraints

  • Side Effects of the Oil and the Product which Contains Cannabidiol

Opportunities

  • Advancements in Product Developments initiated by the Companies Worldwide
  • Partnerships, Joint Ventures, and other Strategies to Improve the Oil Industry’s Offering

Challenges

  • Stringent Transportation Regulations and Increased Warehousing Cost

Market Segmentation

The Global Cannabidiol Oil Market is segmented based on Product, Source, Distribution Channel, Application, and Geography.

  • By Product, the market is classified into Hemp CBD Oil and Marijuana CBD Oil.
  • By Source, the market is classified into Inorganic and Organic.
  • By Distribution Channel, the market is classified into Offline Mode and Online Mode.
  • By Application, the market is classified into Cosmetics, Food & Beverage, Medical & Pharmaceuticals, and Pet Care.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Companies Mentioned

  • Aurora Cannabis, Inc.
  • Canabidol CBD
  • Canopy Growth Corp.
  • CBD Life UK
  • CV Sciences, Inc.
  • Elixinol, LLC
  • Endoca
  • Folium Biosciences
  • GW Pharmaceuticals, PLC
  • Hempura
  • Isodiol International, Inc.
  • Love Hemp, Ltd.
  • Maricann, Inc.
  • Medical Marijuana, Inc.
  • Organigram Holding, Inc.
  • Pharmahemp d.o.o.
  • Provacan
  • The Cronos Group
  • Tikun Olam
  • Tilray Inc.
  • VIVO Cannabis, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2ha6qf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business Wire

Global Cannabidiol Market Report 2022: Growing Acceptance and Use of Products Due to Government Approvals Drives Sector – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “Global Cannabidiol Market (2022-2027) by Type, Distribution Channel, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Cannabidiol Market is estimated to be USD 3.76 Bn in 2022 and is expected to reach USD 8.15 Bn by 2027, growing at a CAGR of 16.72%

Market Dynamics

Drivers

  • Growing Acceptance and Use of Products Due to Government Approvals
  • Rising Demand from Medical and Pharmaceutical Industry
  • Increasing Awareness of Healing Properties of Cannabidiol

Restraints

  • Risk of Side-Effects Such as Dry Mouth, Diarrhea, Reduced Appetite
  • Legal Constraint on Sales of CBD in Some Countries

Opportunities

  • Increasing Customer Inclination Towards Natural or Herbal Remedies/Products
  • Boosting Product Sales Though Alliances With Health and Wellness Retailers

Challenges

  • Lack of Awareness and Standardization in Many Developing Markets

     

     

Market Segmentations

The Global Cannabidiol Market is segmented based on Type, Distribution Channel, End-User, and Geography.

  • By Type, the market is classified into Hemp and Marijuana.
  • By Distribution Channel, the market is classified into B2B and B2C.
  • By End-User, the market is classified into Medical, Personal Use, Pharmaceuticals, and Wellness.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are ABcann Medicinals, Inc., Aphria, Inc, Aurora Cannabis, Cannoid, LLC, Canopy Growth Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Cannabidiol Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Cannabidiol Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Cannabidiol Market, By Type

7 Global Cannabidiol Market, By Distribution Channel

8 Global Cannabidiol Market, By End-User

9 Americas’ Cannabidiol Market

10 Europe’s Cannabidiol Market

11 Middle East and Africa’s Cannabidiol Market

12 APAC’s Cannabidiol Market

13 Competitive Landscape

14 Company Profiles

15 Appendix

Companies Mentioned

  • ABcann Medicinals, Inc.
  • Aphria, Inc
  • Aurora Cannabis
  • Cannoid, LLC
  • Canopy Growth Corp.
  • CBD American Shaman
  • Cura CS
  • CV Sciences, Inc.
  • Elixinol
  • ENDOCA
  • Folium Biosciences
  • GW Pharmaceuticals, PLC
  • HempLife Today, LLC
  • IrieCBD
  • Isodiol International, Inc.
  • Kazmira, LLC
  • Maricann, Inc.
  • MEDICAL MARIJUANA, Inc.
  • Merck KGaA
  • NuLeaf Naturals, LLC
  • Organigram Holding, Inc.
  • Pharmahemp d.o.o.
  • Phyto Animal Health
  • Tikun Olam
  • Tilray

For more information about this report visit https://www.researchandmarkets.com/r/w3new1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories

Published

on

By


HOLY MOUNTAIN product portfolio will primarily focus on value whole flower and concentrates

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of HOLY MOUNTAIN, the Company’s newest value brand featuring an initial lineup of dried flower strains and entering the market with value pressed hash. With the introduction of HOLY MOUNTAIN, Organigram will now offer value-priced flower in an expanded range of sizes, starting with 3.5g offerings at launch and additional sized formats expected soon after.


“The HOLY MOUNTAIN brand will feature iconic flower cultivars including MAC-1 and R*NTZ. Additionally, the 2g Pressed Hash Cube represents the newest hash product being produced at our Quebec-based hash facility located in the foothills of the Tremblant Mountain,” says Eric Williams Senior Director of Marketing at Organigram.

The first HOLY MOUNTAIN products to come to market are:

  • R*NTZ: Featuring fruit, berry and gas aromas, this renowned indica draws on its powerhouse Zkittlez and Gelato lineage and offers a THC range of 18-24%
  • MAC-1: MAC-1 buds pair 18-24% THC with citrus, diesel and spice aromas, and descend from a truly legendary lineage of Miracle 15 and Alien Cookies
  • PRESSED HASH: This 2g hash cube, crafted by the team known for Organigram-owned Tremblant Hash, features classic rich, spicy and herbal aromas and THC of 29-36%

Organigram is currently a leading licensed producer1 in the Canadian cannabis flower category with its two best-selling value brands, SHRED and Big Bag o’ Buds, which play specifically in the pre-milled and 28g whole flower categories, respectively. Consumers and retailers will now have access to Organigram’s high-quality, Moncton-grown whole flower in multiple sizes at an appealing price point.

“Organigram is well known for our commitment to listening closely to our consumers and developing brands and products that respond creatively to their diverse preferences,” says Beena Goldenberg, CEO Organigram. “Our goal is not to be everything to everyone, but rather to have high quality, imaginative products and brands that successfully appeal to, and engage, our targeted consumer segments.”

For more information about HOLY MOUNTAIN, visit holymountaincannabis.ca, @holymountaincannabis on Instagram and follow @holymtncannabis on Twitter.

Finally, Organigram has launched new value brand Wô Lá, which has the same value flower focus as HOLY MOUNTAIN but created specifically for the Quebec market.

Both HOLY MOUNTAIN and Wô Lá are now available at select retailers across Canada.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada.

Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes to market conditions, consumer preferences and regulatory climate, and factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

1 Source: Hifyre retail data, October 2022

Contacts

For Investor Relations enquiries:
investors@organigram.ca

For Media enquiries:
Paolo De Luca
paolo.deluca@organigram.ca
Chief Strategy Officer, Organigram

This post was originally published on this site



Source link

Continue Reading

Business Wire

Leafly to Participate at Upcoming Investor Conferences

Published

on

By


SEATTLE–(BUSINESS WIRE)–Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced that members of its management team will participate in upcoming investor conferences.

Details for the events are as follows:

Cowen 5th Annual Cannabis Conference

Thursday, December 8, 2022, at 12:30 pm ET. A live webcast and replay of the presentation may be accessed from the Events section of Leafly’s Investor Relations website, https://investor.leafly.com/, if available.

The company will also be hosting meetings at the Benchmark Discovery One-on-One Investor Conference on December 1st in New York, NY.

About Leafly

Leafly helps millions of people discover cannabis each year. Our powerful tools help shoppers make informed purchasing decisions and empower cannabis businesses to attract and retain loyal customers through advertising and technology services. Learn more at Leafly.com or download the Leafly mobile app through Apple’s App Store or Google Play.

Contacts

Media
Josh deBerge

josh.deberge@leafly.com
206-445-9387

Investors
Keenan Zopf

IR@leafly.com
Source: Leafly Holdings, Inc.

This post was originally published on this site



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media